Hypochlorous acid-induced oxidative damage of human red blood cells: effects of tert-butyl hydroperoxide and nitrite on the HOCl reaction with erythrocytes.
Hypochlorous acid, one of the most powerful biological oxidants, is believed to be important in the pathogenesis of some diseases. The purpose of this study was to further characterise the membrane and intracellular events which resulted in HOCl-induced oxidative impairments and haemolysis of human erythrocytes and interaction of different oxidative agents, which accumulated during respiratory burst, in the process of RBS oxidation. The sequence of cellular events after red blood cell exposure to HOCl: cell morphological transformations, oxidation of cellular constituents, enzyme modifications, and haemolysis have been evaluated. It was shown that HOCl-treated cells underwent colloid-osmotic haemolysis, preceded by rapid morphological transformations and membrane structural transitions. The activation energy of the process of haemolysis (after removal of the excess of oxidative agent) was estimated to be 146+/-22 kJ/mol at temperatures above the break point of Arrhenius plot (31-32 degrees C). This value corresponds to the activation energy of the process of protein denaturation. Modification of erythrocytes by HOCl inhibited membrane acetylcholinesterase (uncompetitive type of inhibition), depleted intracellular glutathione, activated intracellular glutathione peroxidase, but did not induce membrane lipid peroxidation. The presence of other oxidants, nitrite or tert-butyl hydroperoxide (t-BHP), promoted the oxidative damage induced by HOCl and led to new oxidative reactions.
Zavodnik
Ilya B
IB
Institute of Biochemistry Academy of Sciences of Belarus, 230017 Grodno, Belarus.
Lapshina
Elena A
EA
Zavodnik
Lev B
LB
Soszyński
Mirosław
M
Bartosz
Grzegorz
G
Bryszewska
Maria
M
D000110:Acetylcholinesterase / Q000378:metabolism; D004357:Drug Synergism; D004910:Erythrocyte Membrane / Q000187:drug effects / Q000201:enzymology; D004912:Erythrocytes / Q000187:drug effects* / Q000378:metabolism; D005978:Glutathione / Q000378:metabolism; D006461:Hemolysis / Q000187:drug effects; D006801:Humans; D006997:Hypochlorous Acid / Q000494:pharmacology*; D066298:In Vitro Techniques; D008565:Membrane Proteins / Q000187:drug effects / Q000378:metabolism; D008706:Methemoglobin / Q000378:metabolism; D009573:Nitrites / Q000494:pharmacology*; D016877:Oxidants / Q000494:pharmacology*; D010084:Oxidation-Reduction; D018384:Oxidative Stress / Q000187:drug effects*; D020122:tert-Butylhydroperoxide / Q000494:pharmacology*
D008565:Membrane Proteins; D009573:Nitrites; D016877:Oxidants; D006997:Hypochlorous Acid; D008706:Methemoglobin; D020122:tert-Butylhydroperoxide; D000110:Acetylcholinesterase; D005978:Glutathione